250 related articles for article (PubMed ID: 14597414)
21. Expression of emerin and lamins in muscle of patients with different forms of Emery-Dreifuss muscular dystrophy.
Niebroj-Dobosz I; Fidzianska A; Hausmanowa-Petrusewicz I
Acta Myol; 2003 Sep; 22(2):52-7. PubMed ID: 14959564
[TBL] [Abstract][Full Text] [Related]
22. A LMNA splicing mutation in two sisters with severe Dunnigan-type familial partial lipodystrophy type 2.
Morel CF; Thomas MA; Cao H; O'Neil CH; Pickering JG; Foulkes WD; Hegele RA
J Clin Endocrinol Metab; 2006 Jul; 91(7):2689-95. PubMed ID: 16636128
[TBL] [Abstract][Full Text] [Related]
23. A Novel Lamin A Mutant Responsible for Congenital Muscular Dystrophy Causes Distinct Abnormalities of the Cell Nucleus.
Barateau A; Vadrot N; Vicart P; Ferreiro A; Mayer M; Héron D; Vigouroux C; Buendia B
PLoS One; 2017; 12(1):e0169189. PubMed ID: 28125586
[TBL] [Abstract][Full Text] [Related]
24. Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation.
Frock RL; Kudlow BA; Evans AM; Jameson SA; Hauschka SD; Kennedy BK
Genes Dev; 2006 Feb; 20(4):486-500. PubMed ID: 16481476
[TBL] [Abstract][Full Text] [Related]
25. Lamin A/C mutation associated with lipodystrophy influences adipogenic differentiation of stem cells through interaction with Notch signaling.
Perepelina K; Dmitrieva R; Ignatieva E; Borodkina A; Kostareva A; Malashicheva A
Biochem Cell Biol; 2018 Jun; 96(3):342-348. PubMed ID: 29040816
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the LMNA gene encoding lamin A/C.
Genschel J; Schmidt HH
Hum Mutat; 2000 Dec; 16(6):451-9. PubMed ID: 11102973
[TBL] [Abstract][Full Text] [Related]
27. Emerin-prelamin A interplay in human fibroblasts.
Capanni C; Del Coco R; Mattioli E; Camozzi D; Columbaro M; Schena E; Merlini L; Squarzoni S; Maraldi NM; Lattanzi G
Biol Cell; 2009 Sep; 101(9):541-54. PubMed ID: 19323649
[TBL] [Abstract][Full Text] [Related]
28. BAF is required for emerin assembly into the reforming nuclear envelope.
Haraguchi T; Koujin T; Segura-Totten M; Lee KK; Matsuoka Y; Yoneda Y; Wilson KL; Hiraoka Y
J Cell Sci; 2001 Dec; 114(Pt 24):4575-85. PubMed ID: 11792822
[TBL] [Abstract][Full Text] [Related]
29. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.
Bakay M; Wang Z; Melcon G; Schiltz L; Xuan J; Zhao P; Sartorelli V; Seo J; Pegoraro E; Angelini C; Shneiderman B; Escolar D; Chen YW; Winokur ST; Pachman LM; Fan C; Mandler R; Nevo Y; Gordon E; Zhu Y; Dong Y; Wang Y; Hoffman EP
Brain; 2006 Apr; 129(Pt 4):996-1013. PubMed ID: 16478798
[TBL] [Abstract][Full Text] [Related]
30. Dependence of diffusional mobility of integral inner nuclear membrane proteins on A-type lamins.
Ostlund C; Sullivan T; Stewart CL; Worman HJ
Biochemistry; 2006 Feb; 45(5):1374-82. PubMed ID: 16445279
[TBL] [Abstract][Full Text] [Related]
31. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity.
Zhang Q; Bethmann C; Worth NF; Davies JD; Wasner C; Feuer A; Ragnauth CD; Yi Q; Mellad JA; Warren DT; Wheeler MA; Ellis JA; Skepper JN; Vorgerd M; Schlotter-Weigel B; Weissberg PL; Roberts RG; Wehnert M; Shanahan CM
Hum Mol Genet; 2007 Dec; 16(23):2816-33. PubMed ID: 17761684
[TBL] [Abstract][Full Text] [Related]
32. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.
Speckman RA; Garg A; Du F; Bennett L; Veile R; Arioglu E; Taylor SI; Lovett M; Bowcock AM
Am J Hum Genet; 2000 Apr; 66(4):1192-8. PubMed ID: 10739751
[TBL] [Abstract][Full Text] [Related]
33. Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci.
Manju K; Muralikrishna B; Parnaik VK
J Cell Sci; 2006 Jul; 119(Pt 13):2704-14. PubMed ID: 16772334
[TBL] [Abstract][Full Text] [Related]
34. Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells.
Lammerding J; Hsiao J; Schulze PC; Kozlov S; Stewart CL; Lee RT
J Cell Biol; 2005 Aug; 170(5):781-91. PubMed ID: 16115958
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene.
Garg A; Vinaitheerthan M; Weatherall PT; Bowcock AM
J Clin Endocrinol Metab; 2001 Jan; 86(1):59-65. PubMed ID: 11231979
[TBL] [Abstract][Full Text] [Related]
36. Pushing the envelope on lipodystrophy.
Flier JS
Nat Genet; 2000 Feb; 24(2):103-4. PubMed ID: 10655047
[TBL] [Abstract][Full Text] [Related]
37. Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes?
Hutchison CJ; Alvarez-Reyes M; Vaughan OA
J Cell Sci; 2001 Jan; 114(Pt 1):9-19. PubMed ID: 11112685
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
Hegele RA; Cao H; Anderson CM; Hramiak IM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3431-5. PubMed ID: 10999845
[TBL] [Abstract][Full Text] [Related]
39. Both lamin A and lamin C mutations cause lamina instability as well as loss of internal nuclear lamin organization.
Broers JL; Kuijpers HJ; Ostlund C; Worman HJ; Endert J; Ramaekers FC
Exp Cell Res; 2005 Apr; 304(2):582-92. PubMed ID: 15748902
[TBL] [Abstract][Full Text] [Related]
40. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy.
Vigouroux C; Magré J; Vantyghem MC; Bourut C; Lascols O; Shackleton S; Lloyd DJ; Guerci B; Padova G; Valensi P; Grimaldi A; Piquemal R; Touraine P; Trembath RC; Capeau J
Diabetes; 2000 Nov; 49(11):1958-62. PubMed ID: 11078466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
